CRKL and chronic myelogenous leukemia, BCR-ABL1 positive: Similar to previously published papers with iPSCs derived from CML cell lines [19] and more recently from CML primary cells [20], [21], we found that CML-iPSCs generated expressed BCR-ABL1, but were resistant to imatinib, even after Crkl phosphorylation inhibition.